Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas - PubMed (original) (raw)

Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas

S H Torp et al. Acta Neurochir (Wien). 1992.

Abstract

The aim of this study was to determine possible relationships between Ki-67 labelling index (Ki-67 LI), amplification of the epidermal growth factor receptor (EGFR) gene, and prognosis in human glioblastomas. Ki-67 LI was determined on cryosections of biopsy specimens of 20 human glioblastomas with a mouse anti-human Ki-67 monoclonal antibody. Amplification of the EGFR gene was determined by slot blot and Southern blot analyses of DNA extracted from the tumour biopsies. The Ki-67 LI was higher in the glioblastoma group with EGFR gene amplification (8 tumours, median value of Ki-67 LI 4.2, range 0.4-24.6) than in those without EGFR gene amplification (12 tumours, median value of Ki-67 LI 0.8, range 0.2-11.8) (0.05 p less than 0.1). The glioblastoma patients with Ki-67 LI greater than 1.5 (10 tumours) had a statistically significant shorter survival than those with Ki-67 LI less than 1.5 (10 tumours) (p less than 0.05). The glioblastoma patients with EGFR gene amplification lived shorter time than those without EGFR gene amplification (p greater than 0.05).

PubMed Disclaimer

Similar articles

Cited by

References

    1. Acta Neurochir (Wien). 1987;89(3-4):117-21 - PubMed
    1. Anal Biochem. 1983 Jun;131(2):538-47 - PubMed
    1. J Neurosurg. 1991 Jul;75(1):97-102 - PubMed
    1. Int J Cancer. 1983 Jan 15;31(1):13-20 - PubMed
    1. Nature. 1985 Jan 10-18;313(5998):144-7 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources